Skip to product information
1 of 1

Rig-I/DDX58 Recombinant Rabbit mAb (S-1419-114)

Rig-I/DDX58 Recombinant Rabbit mAb (S-1419-114)

Catalog Number: S0B6184 Application: WB Reactivity: Human,Mouse Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:
For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen Rig-I/DDX58
Synonyms Antiviral innate immune response receptor RIG-I; ATP-dependent RNA helicase DDX58; DEAD box protein 58; RIG-I-like receptor 1 (RLR-1); RNA sensor RIG-I; Retinoic acid-inducible gene 1 protein (RIG-1); Retinoic acid-inducible gene I protein (RIG-I); DDX58; RIGI
Immunogen Synthetic Peptide
Location Cytoplasm, Cell junction
Accession O95786
Clone Number S-1419-114
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu, Ms
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu, Ms

Background

Rig-I (Retinoic acid-inducible gene I) is a crucial cytosolic pattern recognition receptor (PRR) in the innate immune system, belonging to the DExD/H-box RNA helicase family. It primarily detects viral RNA, such as short double-stranded RNA (dsRNA) with a 5'-triphosphate group (5'-ppp) or single-stranded RNA (ssRNA) with short stem-loop structures, thereby triggering antiviral immune responses. Structurally, Rig-I consists of two N-terminal tandem CARD domains (for signal transduction), a central DExD/H-box helicase domain (responsible for RNA binding and ATP hydrolysis), and a C-terminal regulatory domain (CTD, which specifically recognizes viral RNA). Upon binding viral RNA, Rig-I interacts with the mitochondrial antiviral signaling protein (MAVS) via its CARD domains, activating the IRF3/7 and NF-κB pathways to induce the production of type I interferons and pro-inflammatory cytokines. This protein plays a central role in defending against RNA viruses (e.g., influenza virus, hepatitis C virus), and its dysfunction is closely associated with autoimmune diseases and increased susceptibility to viral infections.

Picture

Western Blot

WB result of Rig-I/DDX58 Recombinant Rabbit mAb
Primary antibody: Rig-I/DDX58 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated THP-1 whole cell lysate 20 µg
Lane 2: THP-1 treated with 50 nM PMA and 5 µg/ml LPS for 24 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 102 kDa
Observed MW: 110 kDa

WB result of Rig-I/DDX58 Recombinant Rabbit mAb
Primary antibody: Rig-I/DDX58 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: untreated RAW264.7 whole cell lysate 20 µg
Lane 2: RAW264.7 treated with 0.1 µg/ml LPS for 6 hours whole cell lysate 20 µg
Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 102 kDa
Observed MW: 115 kDa

Customer Reviews

Be the first to write a review
0%
(0)
0%
(0)
0%
(0)
0%
(0)
0%
(0)